It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

And it’s not just cuddling by an open fire that puts you at risk: The hallmarks of the winter season, including lower ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Since the holidays, there's been an uptick in cases of flu and other viruses in the region, health officials say.

Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen ...

In the winter, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. But there are things you ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Here are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...